期刊论文详细信息
BMC Public Health
Getting better at chronic care in remote communities: study protocol for a pragmatic cluster randomised controlled of community based management
Robyn McDermott6  Alex Sticpewich2  Cilla Preece2  Sean Taylor2  Leonie Segal3  Wendy Hoy1  Adrian Esterman4  Mark Wenitong5  Barbara Schmidt2 
[1] University of Queensland School of Medicine, Centre for Chronic Disease, Health Sciences Building, Level 8 Royal Brisbane and Womens Hospital, Herston, Brisbane, 4029, Australia;Getting Better at Chronic Care Project, University of South Australia, School of Health Sciences, Cairns Diabetes Centre, 381 Sheridan St, North Cairns, QLD, 4870, Australia;School of Nursing and Midwifery, Division of Health Sciences, University of South Australia, Playford Building P4-26, City East Campus, North Terrace, Adelaide, 5000, S.A, Australia;Sansom Institute of Health Service, School of Health Sciences, University of South Australia, Level 6, Centenary Building, North Terrace, Adelaide, 5000, Australia;Apunipima Cape York Health Council, 186 McCoombe St, Bungalow Cairns, QLD, 4870, Australia;Sansom Institute of Health Service, School of Health Sciences, University of South Australia, University of South Australia City East Campus North Terrace, Adelaide, 5000, S.A, Australia
关键词: HbA1c control;    Partnerships;    Indigenous Health Worker;    Diabetes;    Aboriginal and Torres Strait Islander;   
Others  :  1162791
DOI  :  10.1186/1471-2458-12-1017
 received in 2012-11-05, accepted in 2012-11-12,  发布年份 2012
PDF
【 摘 要 】

Background

Prevalence and incidence of diabetes and other common comorbid conditions (hypertension, coronary heart disease, renal disease and chronic lung disease) are extremely high among Indigenous Australians. Recent measures to improve quality of preventive care in Indigenous community settings, while apparently successful at increasing screening and routine check-up rates, have shown only modest or little improvements in appropriate care such as the introduction of insulin and other scaled-up drug regimens in line with evidence-based guidelines, together with support for risk factor reduction. A new strategy is required to ensure high quality integrated family-centred care is available locally, with continuity and cultural safety, by community-based care coordinators with appropriate system supports.

Methods/design

The trial design is open parallel cluster randomised controlled trial. The objective of this pragmatic trial is to test the effectiveness of a model of health service delivery that facilitates integrated community-based, intensive chronic condition management, compared with usual care, in rural and remote Indigenous primary health care services in north Queensland. Participants are Indigenous adults (aged 18–65 years) with poorly controlled diabetes (HbA1c>=8.5) and at least one other chronic condition. The intervention is to employ an Indigenous Health Worker to case manage the care of a maximum caseload of 30 participants. The Indigenous Health Workers receive intensive clinical training initially, and throughout the study, to ensure they are competent to coordinate care for people with chronic conditions. The Indigenous Health Workers, supported by the local primary health care (PHC) team and an Indigenous Clinical Support Team, will manage care, including coordinating access to multidisciplinary team care based on best practice standards. Allocation by cluster to the intervention and control groups is by simple randomisation after participant enrolment. Participants in the control group will receive usual care, and will be wait-listed to receive a revised model of the intervention informed by the data analysis. The primary outcome is reduction in HbA1c measured at 18 months. Implementation fidelity will be monitored and a qualitative investigation (methods to be determined) will aim to identify elements of the model which may influence health outcomes for Indigenous people with chronic conditions.

Discussion

This pragmatic trial will test a culturally-sound family-centred model of care with supported case management by IHWs to improve outcomes for people with complex chronic care needs. This trial is now in the intervention phase.

Trial registration

Australian New Zealand Clinical Trials Registry ACTR12610000812099

【 授权许可】

   
2012 Schmidt et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150413080937765.pdf 455KB PDF download
Figure 1. 77KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Vos T, Barker B, Begg S, Stanley L, Lopez AD: Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol 2009, 38(2):470-477.
  • [2]Australian Instititue of Health and Welfare: Australia's Health 2008. Canberra: AIHW; 2008:336.
  • [3]UK Prospective Diabetes Study Group: Tight blood pressure control reduced diabetes related deaths and complications and was cost effective in type 2 diabetes. Evid Based Med 1999, 317(4):12-13.
  • [4]Australian Diabetes Society: Australian Diabetes Society Position Statement: Individualisation of HbA1c targets for adults with diabetes mellitis. 2009.
  • [5]Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas R, Wender R, Matthews DR: Management of hyperglycaemia in type 2 diabetes: a patient centred approach. Position statement of the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD). Diabetologia 2012, 55(6):1577-1596.
  • [6]Turner RC, Cull CA, Frighi V, Holman RR: Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. J Am Med Assoc 1999, 281(21):2005-2012.
  • [7]Fioretto P, Bruseghin M, Berto I, Gallina P, Manzato E, Mussap M: Renal protection in diabetes: Role of glycemic control. J Am Soc Nephrol 2006, 17(4 suppl 2):S86-S89.
  • [8]Queensland Health: Chronic Disease Guidelines. 3rd edition. publisher; 2010. Webpage
  • [9]Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, Leong-Grotz K, Castro C, Bindman AB: Closing the loop: Physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003, 163(1):83-90.
  • [10]Hoy W, Davey R, Sharma S, Hoy P, Smith J, Kondalsamy-Chennakesavan S: Chronic disease profiles in remote Aboriginal settings and implications for health service planning. Aust New Zeal J Publ Health 2010, 34(1):11-18.
  • [11]Bailie R, Si D, Robinson G: A multi-faceted health-service intervention in remote Aboriginal communities: 3-year follow-up of the impact on diabetes care. Med J Aust 2004, 181:195-200.
  • [12]Acton KJ, Shields R, Rith-Najarian S, Tolbert B, et al.: Applying the Diabetes Quality Improvement Project indicators in the Indian Health Service primary care setting. Diabetes Care 2001, 24(1):22-26.
  • [13]McDermott R, Schmidt B, Sinha A, Mills P: Improving diabetes care in the primary healthcare setting: a randomised cluster trial in remote Indigenous communities. Med J Aust 2001, 174:497-502.
  • [14]McDermott R, Tulip F, Schmidt B, Sinha A: Sustaining better diabetes care in remote Indigenous Australian communities. BMJ 2003, 327(7412):428-430.
  • [15]McDermott R, Segal L: Impact study of improved primary level diabetes care in remote Australian Indigenous communities. Aust J Prim Health Care 2006, 12(2):124-130.
  • [16]Hoy WE, Baker P, Kelly A, Wang Z: Reducing premature death and renal failure in Australian Aboriginals: a community-based cardiovascular and renal protective program. Med J Aust 2000, 172(10):473-478.
  • [17]Baker P, Hoy W, Thomas R: Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population. Adv Kidney Dis 2005, 12(1):124-130.
  • [18]Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J, Sharma S, Katz I: A chronic disease outreach program for Aboriginal communities. Kidney Int 2005, 68(S98):S76-S82.
  • [19]McDermott RA, McCulloch BG, Campbell SK, Young DM: Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999–2005. Med J Aust 2007, 186(10):505-508.
  • [20]Queensland Health: Health Indicators in far north Queensland. Cairns: Tropical Public Health Unit; 2007.
  • [21]McDermott RA, Tulip F, Schmidt B: Diabetes care in remote northern Australian Indigenous communities. Med J Aust 2004, 180(10):512-516.
  • [22]UK Prospective Diabetes Study Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes mellitus. Lancet 1998, 184(7):837-853.
  • [23]Davis TME, Davis WA, Bruce DG: Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Aust 2006, 184(7):325-328.
  • [24]Apunipima Cape York Health Council: Comprehensive Primary Health Care and the Family Centred Model. Cairns: ACYHC; 2008.
  • [25]Glasgow RE: Translating Research to Practice. Diabetes Care 2003, 26(8):2451-2456.
  • [26]Puffer S, Torgerson DJ, Watson J: Cluster randomized controlled trials. J Eval Clin Pract 2005, 11(5):479-483.
  • [27]Queensland Health: Aboriginal and Torres Strait Islander Health Worker Career Structure. Queensland Health; 2009.
  • [28]Queensland Government: Queensland Strategy for Chronic Disease. Queensland Health; 2005.
  • [29]Karter A, Moffet H, Liu J, Parker M, Ahmed A, Ferrara A, Selby J: Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. Am J Manag Care 2005, 11(4):262-270.
  • [30]Department of Health and Ageing: National Strategic Framework for Aboriginal and Torres Strait Islander Health. 2003, 12.
  • [31]Queensland Health: Making Tracks towards closing the gap in health outcomes for Indigenous Queenslanders by 2033 – Policy and accountability framework. Brisbane: Queensland Health; 2010:43.
  • [32]Gracey M, King M: Indigenous health part 1: determinants and disease patterns. Lancet 2009, 374(9683):65-75.
  • [33]Wakerman J, Chalmers EM, Humphreys JS, Clarence CL, et al.: Sustainable chronic disease management in remote Australia. Med J Aust 2005, 183(10):S64-S68.
  • [34]Zwarenstein M, Treweek S, Gagnier J, Altman D, Tunis S, Haynes B, Oxman A, Moher D: Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Br Med J 2009, 337:a2718. Nov
  • [35]Keith R, Hopp F, Subramanian U, Wiitala W, Lowery J: Fidelity of implementation: development and testing of a measure. Implement Sci 2010, 5(1):99. BioMed Central Full Text
  文献评价指标  
  下载次数:24次 浏览次数:19次